Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Cocrystal Pharma, Inc. (3) Acquired (3)
amdoxovir (3 trials)
cc-42344 (2 trials)
sofosbuvir (sovaldi) (1 trial)
tenofovir (viread) (1 trial)
velpatasvir (Epclusa) (2 trials)
zidovudine (retrovir) (1 trial)
cdi-988 (1 trial)
Hepatitis (Phase 2)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 2)
Hepatitis, Chronic (Phase 2)
Trials (8 total)
Trial APIs (7 total)